Appelhans Dannielle's Form 4 filing
Rubius Therapeutics, Inc. (RUBY) · filed Feb 1, 2023
- Accession no.
- 0001104659-23-009464
- Filed
- Feb 1, 2023, 9:40 PM ET
- Trade date
- Jan 31-Feb 1, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $969.5. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Appelhans DannielleCIK 0001874962 | Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | Common Stock | MOption exerciseAcquired | +7,500 | –F1 | – | 14,263 | Direct | |
| Feb 1, 2023 | Common Stock | SSaleDisposed | −3,878 | $0.25 | −$969.5 | 10,385 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 22,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Referenced by the price of 1 transaction in Table I.
Remarks
Exhibit List - Exhibit 24 - Power of Attorney